{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:22:06Z","timestamp":1794270126179,"version":"4.9.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100014219","name":"National Science Fund for Distinguished Young Scholars","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005153","name":"National Science Fund for Distinguished Young Scholars","doi-asserted-by":"publisher","award":["82404762"],"award-info":[{"award-number":["82404762"]}],"id":[{"id":"10.13039\/501100005153","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijantimicag.2026.107944","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:26:13Z","timestamp":1785367573000},"page":"107944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimising the meropenem dosing regimen in neonates: A dual-centre cohort study"],"prefix":"10.1016","volume":"67","author":[{"given":"Tao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taotao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5619-0788","authenticated-orcid":false,"given":"Yalin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107944_bib0001","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4103\/aam.aam_34_16","article-title":"Neonatal sepsis in a Nigerian private tertiary hospital: bacterial isolates, risk factors, and antibiotic susceptibility patterns","volume":"16","author":"Shobowale","year":"2017","journal-title":"Ann Afr Med"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0002","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s40262-023-01230-w","article-title":"Optimization of \u03b2-lactam dosing regimens in neonatal infections: continuous and extended administration versus intermittent administration","volume":"62","author":"Leegwater","year":"2023","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0003","article-title":"Use of newer and repurposed antibiotics against gram-negative bacteria in neonates","volume":"12","author":"Kontou","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0004","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Disease","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0005","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Collaborators","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0006","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.29271\/jcpsp.2020.12.1312","article-title":"Emerging antimicrobial resistance in neonatal sepsis","volume":"30","author":"Hashmi","year":"2020","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0007","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7905727","article-title":"Neonatal sepsis in a resource-limited setting: causative microorganisms and antimicrobial susceptibility profile","volume":"2022","author":"Acheampong","year":"2022","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0008","first-page":"14","article-title":"Development of a bloodstream infection surveillance programme at a resource-limited South African neonatal unit","author":"Ashton","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0009","article-title":"Clinical and microbiological profile of culture-positive neonatal sepsis in a tertiary care center in North India","volume":"17","author":"Kartik","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0010","doi-asserted-by":"crossref","first-page":"238","DOI":"10.5152\/TurkArchPediatr.2024.23245","article-title":"Clinical challenge: standard versus extended meropenem infusion in children","volume":"59","author":"Ki\u015fi","year":"2024","journal-title":"Turk Arch Pediatr"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1079680","article-title":"Population PK\/PD modelling of meropenem in preterm newborns based on therapeutic drug monitoring data","volume":"14","author":"Zyryanov","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0012","article-title":"Antibiotics, analgesic sedatives, and antiseizure medications frequently used in critically ill neonates: a narrative review","volume":"11","author":"Kontou","year":"2024","journal-title":"Children (Basel)"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1159798","article-title":"Revisiting ESKAPE pathogens: virulence, resistance, and combating strategies focusing on quorum sensing","volume":"13","author":"Venkateswaran","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2026.107944_bib0014","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1086\/590064","article-title":"Pharmacokinetic and pharmacodynamic properties of meropenem","volume":"47","author":"Nicolau","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0015","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pedneo.2023.09.008","article-title":"Evaluation of pharmacokinetic pharmacodynamic target attainment of meropenem in pediatric patients","volume":"65","author":"Alsultan","year":"2024","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0016","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1111\/bcp.15308","article-title":"Optimal dose of meropenem for the treatment of neonatal sepsis: dosing guideline variations and clinical practice deviations","volume":"88","author":"Raza","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105221","article-title":"Optimal use of \u03b2-lactams in neonates: machine learning-based clinical decision support system","volume":"105","author":"Tang","year":"2024","journal-title":"Ebiomedicine"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15122765","article-title":"Physiologically based pharmacokinetic modeling in neonates: current status and future perspectives","volume":"15","author":"Zhang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12070685","article-title":"Approaches to dose finding in neonates, illustrating the variability between neonatal drug development programs","volume":"12","author":"Van den Anker","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/FTD.0000000000000919","article-title":"Therapeutic drug monitoring of antimicrobial drugs in neonates: an opinion article","volume":"44","author":"Touw","year":"2022","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0021","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.2174\/1381612823666170926121124","article-title":"Developmental pharmacokinetics in neonates: maturational changes and beyond","volume":"23","author":"Allegaert","year":"2017","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0022","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00467-018-4120-2","article-title":"Augmented renal clearance in pediatric intensive care: are we undertreating our sickest patients?","volume":"35","author":"Dhont","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0023","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40262-014-0209-3","article-title":"Interethnic differences in pharmacokinetics of antibacterials","volume":"54","author":"Tsai","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0024","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2165\/00003088-200645100-00001","article-title":"Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics","volume":"45","author":"Chen","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0025","unstructured":"EMC. Meronem IV 1g Powder for solution for injection or infusion. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/9834\/smpc. [accessed 06.02.26]"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0026","unstructured":"LHSC. MEROPENEM. Available from: https:\/\/www.lhsc.on.ca\/nicu\/meropenem. [accessed 06.02.26]"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229380","article-title":"Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): a randomised controlled trial","volume":"15","author":"Lutsar","year":"2020","journal-title":"Plos One"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0028","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","article-title":"A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine","volume":"58","author":"Schwartz","year":"1976","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0029","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/bcpt.13303","article-title":"Desired vancomycin trough concentration to achieve an AUC(0-24) \/MIC >\/=400 in Chinese children with complicated infectious diseases","volume":"126","author":"Zhang","year":"2020","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.594562","article-title":"Population pharmacokinetics and model-based dosing optimization of Teicoplanin in pediatric patients","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0031","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF01060893","article-title":"Some suggestions for measuring predictive performance","volume":"9","author":"Sheiner","year":"1981","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0032","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.3389\/fmicb.2019.02777","article-title":"Is Meropenem as a monotherapy truly incompetent for Meropenem-nonsusceptible bacterial strains? A pharmacokinetic\/pharmacodynamic modeling with Monte Carlo simulation","volume":"10","author":"Song","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0033","unstructured":"EUCAST. Breakpoint tables for interpretation of MICs and zone diameters (Version 15.0). Available from: https:\/\/www.eucast.org\/bacteria\/clinical-breakpoints-and-interpretation\/clinical-breakpoint-tables\/. [accessed 07.07.2025]."},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0034","article-title":"Meropenem disposition in neonatal and pediatric extracorporeal membrane oxygenation and continuous renal replacement therapy","volume":"13","author":"Pokorn\u00e1","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0035","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1128\/AAC.00351-09","article-title":"Meropenem pharmacokinetics in the newborn","volume":"53","author":"van den Anker","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0036","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1016\/j.xphs.2021.05.019","article-title":"Optimizing meropenem therapy for severe nosocomial infections in neonates","volume":"110","author":"Lima-Rogel","year":"2021","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0037","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01909-20","article-title":"Population pharmacokinetics and pharmacodynamics of meropenem in critically ill pediatric patients","volume":"65","author":"Saito","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0038","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s40262-025-01495-3","article-title":"Variability in meropenem distribution and clearance in children with sepsis: population-based pharmacokinetics with assessment of renal biomarkers","volume":"64","author":"Le","year":"2025","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0039","article-title":"Developmental population pharmacokinetics-pharmacodynamics of meropenem in Chinese neonates and young infants: dosing recommendations for late-onset sepsis","volume":"9","author":"Wu","year":"2022","journal-title":"Children (Basel)"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0040","article-title":"From PICU to NICU: extrapolating meropenem exposure From pediatric to neonatal intensive care patients","author":"Morales Junior","year":"2025","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0041","article-title":"A review of the mechanism of action of drugs used in congestive heart failure in pediatrics","volume":"15","author":"Singh","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0042","first-page":"203","article-title":"Pharmacokinetics of fentanyl in children with different types of congenital heart disease","volume":"18","author":"Kaizhi","year":"1998","journal-title":"J North China Univers Sci Technol"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0043","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s11095-016-1856-x","article-title":"Simulation-based evaluation of PK\/PD indices for meropenem across patient groups and experimental designs","volume":"33","author":"Kristoffersson","year":"2016","journal-title":"Pharm Res"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0044","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14051488","article-title":"A real-life study of prolonged meropenem infusion in neonates and children admitted to intensive care units: are three hours long enough?","volume":"14","author":"Mariani","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0045","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.kint.2022.10.015","article-title":"Estimating glomerular filtration rate from serum creatinine concentration in children with augmented renal clearance: all formulas are equivocal, but some are more equivocal than others","volume":"103","author":"Andre","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0046","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1681\/ASN.2021101326","article-title":"Maturation of GFR in term-born neonates: an individual participant data meta-analysis","volume":"33","author":"Smeets","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0047","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae631.1338","article-title":"p - 1152. Cefepime, Meropenem, and piperacillin therapeutic drug monitoring in neonatal and pediatric patients","volume":"12","author":"Dinnes","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0048","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1093\/jac\/dkx209","article-title":"Too much of a good thing: a retrospective study of beta-lactam concentration-toxicity relationships","volume":"72","author":"Imani","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0049","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01564-21","article-title":"Target site pharmacokinetics of meropenem: measurement in human explanted lung tissue by bronchoalveolar lavage, microdialysis, and homogenized lung tissue","volume":"65","author":"Paal","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0050","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/INF.0b013e31822e8b0b","article-title":"Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections","volume":"30","author":"Smith","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0051","first-page":"2260","article-title":"Meta-analysis of the safety of meropenem for neonatal infection","volume":"32","author":"Lulu","year":"2021","journal-title":"China Pharmacy"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0052","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/cid\/cis758","article-title":"Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections","volume":"55","author":"Cohen-Wolkowiez","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0053","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13256-020-02632-1","article-title":"Meropenem-induced pancytopenia in a preterm neonate: a case report","volume":"15","author":"Hussain","year":"2021","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0054","first-page":"353","article-title":"Meropenem-induced neutropenia in a neonate","volume":"21","author":"Van Tuyl","year":"2016","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JPI-130375","article-title":"Meropenem-associated severe neutropenia in an infant with brain abscess","volume":"8","author":"Burckhardta","year":"2013","journal-title":"J Pediatr Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107944_bib0056","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1128\/AAC.00655-12","article-title":"Short versus long infusion of meropenem in very-low-birth-weight neonates","volume":"56","author":"Padari","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926002311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926002311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:36:36Z","timestamp":1794267396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926002311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0924857926002311"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107944","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimising the meropenem dosing regimen in neonates: A dual-centre cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107944","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107944"}}